Remove Government Remove IPO Remove Public Trading
article thumbnail

Will Cava Going Public Set the Table for Other IPOs?

Successful Acquisitions

Will Cava Going Public Set the Table for Other IPOs? By David Braun, Founder and CEO, Capstone Strategic When Washington DC based restaurant chain Cava became a publicly traded company recently, it bucked a trend that has lasted nearly two years, a notable absence of American IPOs.

IPO 111
article thumbnail

Will There Be an IPO for a Specialty Consulting Company in 2024?

Focus Investment Banking

In that environment, very few firms sought IPOs, and there was a major slowdown in overall exits, whether private or public. And will that mean that some of the privately held management consulting firms or other professional services companies will choose an IPO this year? Contact Kelly at Kelly.Kittrell@focusbankers.com.

IPO 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dual-Track Processes: How to Turbocharge Your Exit

Cooley M&A

Whether there’s a looming threat of a government shutdown or a sudden stock market sell-off, or the auction bids come in below expectations, the alternative track may present a superior exit option. Is the objective to achieve a partial or complete exit? For either track, a partial exit gives rise to the question of control.

IPO 52
article thumbnail

Highlights from Cooley’s M&A Dealmakers Roundtable: SPACs!

Cooley M&A

is the increased frequency at which SPAC IPOs are occurring. As reflected in Chart 1 , 102 SPAC IPOs have been announced this year as of September 18, 2020—almost double the number of SPAC IPOs in all of last year (and more than double the number of SPAC IPOs in 2018). SPAC vs. IPO. A distinct feature of SPAC 3.0

M&A 52
article thumbnail

MergersCorp Expands Services to SPAC Companies Amid Growing Market Demand

MergersCorp M&A International

SPACs are publicly traded companies that raise capital through an initial public offering (IPO) with the primary aim of acquiring an existing private company, thereby enabling it to go public without undergoing the traditional IPO process.

article thumbnail

A welcome freedom, temporary measure or futile task?: The industry reacts to the UK’s new research proposal

The TRADE

To help boost the attractiveness of the UK’s financial services sector, the UK government revealed last night that it had accepted all recommendations from Rachel Kent’s UK Investment Research Review, published yesterday.

article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Novartis announced plans to spin off its generics and biosimilars division into a publicly traded stand-alone company. Let’s dig in.

M&A 40